Antibody responses to antigenic sites 1 and 3 of serotype 3 poliovirus after vaccination with oral live attenuated or inactivated poliovirus vaccine and after natural exposure

Clinical and Diagnostic Laboratory Immunology

Volumn 7, Issue 1, 2000, Pages 40-44

  Herremans, T ^a   Reimerink, J H J ^a   Kimman, T G ^a   Van Der Avoort, H G A M ^a   Koopmans, M P G ^a  

^a NATIONAL INSTITUTE FOR PUBLIC HEALTH AND THE ENVIRONMENT   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

POLIOMYELITIS VACCINE;

ANTIBODY RESPONSE; ARTICLE; HUMAN; IMMUNE RESPONSE; IMMUNIZATION; IMMUNOGENICITY; POLIOMYELITIS VIRUS; PRIORITY JOURNAL; SEROTYPE; VIRUS NEUTRALIZATION;

EID: 0033965422     PISSN: 1071412X     EISSN: None     Source Type: Journal    
DOI: 10.1128/cdli.7.1.40-44.2000     Document Type: Article

References (28)

1. Cello, J., O. Strannegrad, and B. Svennerholm. 1996. A study of the cellular immune response to enteroviruses in humans: identification of cross-reactive T cell epitopes on the structural proteins of enteroviruses. J. Gen. Virol. 77:2097-2108.
2. Chaplin, H., S. Cohen, and E. M. Press. 1965. Preparation and properties of the peptide chains of normal human 19 s γ-globulin (IgM). Biochem. J. 95:256-261.
3. Conyn-Spaendonck, M. A. E., P. M. Oostvogel, A. M. van Loon, J. K. van Wijngaarden, and D. Kromhout. 1996. Circulation of poliovirus during the poliomyelitis outbreak in The Netherlands in 1992-1993. Am. J. Epidemiol. 143:929-934.
4. Emini, E. A., B. A. Jameson, A. J. Lewis, G. R. Larsen, and E. Wimmer. 1982. Poliovirus neutralizing epitopes: analysis and location with neutralizing monoclonal antibodies. J. Virol. 43:997-1005.
5. Fricks, C. E., J. P. Icenogle, and J. M. Hogle. 1985. Trypsin sensitivity of the Sabin strain of type 1 poliovirus: cleavage sites in virions and related particles. J. Virol. 54:856-859.
6. Harber, J., G. Bernhardt, H. H. Lu, J. Y. Sgro, and E. Wimmer. 1995. Canyon rim residues, including antigenic determinants, modulate serotype-specific binding of polioviruses to mutants of the poliovirus receptor. Virology 20:559-570.
7. Herremans, M. M. P. T., J. H. R. Reimerink, A. Ras, H. G. A. M. van der Avoort, T. G. Kimman, A. M. van Loon, M. A. E. Conyn-van Spaendonck, and M. P. G. Koopmans. 1997. Evaluation of a poliovirus-binding inhibition assay as an alternative to the virus neutralization test. Clin. Diagn. Lab. Immunol. 4:659-664.
8. Herremans, M. M. P. T., A. M. van Loon, J. H. J. Reimerink, H. C. Rumke, H. G. A. M. van der Avoort, T. G. Kimman, and M. P. G. Koopmans. 1997. Poliovirus-specific immunoglobulin A in persons vaccinated with inactivated poliovirus vaccine in The Netherlands. Clin. Diagn. Lab. Immunol. 4:499-503.
9. Herremans, M. M. P. T., J. H. J. Reimerink, A. M. Buisman, T. G. Kimman, and M. P. G. Koopmans. 1999. Induction of mucosal immunity by inactivated poliovirus vaccine is dependent on previous mucosal contact with live virus. J. Immunol. 162:5011-5018.
10. Hogle, J. M., M. Chow, and D. J. Filman. 1985. The three-dimensional structure of poliovirus at 2.9A resolution. Science 229:1358-1365.
11. Hovi, T., K. Cantell, A. Huovilainen, E. Kinnunen, T. Kuronen, K. Lapinleimu. T. Poyry, M. Roivainen, N. Salama, and M. Stenvik. 1986. Outbreak of paralytic poliomyelitis in Finland: widespread circulation of antigenically altered poliovirus type 3 in a vaccinated population. Lancet 21:1427-1432.
12. Icenogle, J. P., P. D. Minor, M. Ferguson, and J. M. Hogle. 1986. Modulation of humoral responses to a 12-amino-acid site on the poliovirus. J. Virol. 60:297-301.
13. Kersten, G. F. A., M. Lantinga, T. Hazendonk, and E. C. Beuvery. 1995. Immunogenicity of trypsin treated type 2 and type 3 poliovirus in rats. Biologicals 23:179-183.
14. Magrath, D. I., D. M. Evans, M. Ferguson, G. C. Schild, P. D. Minor, F. Horaud, R. Crainic, M. Stenvik, and T. Hovi. 1986. Antigenic and molecular properties of type 3 poliovirus responsible for an outbreak of poliomyelitis in a vaccinated population. J. Gen. Virol. 67:899-905.
15. Minor, P. D., D. M. Evans, M. Ferguson, G. C. Schild, G. Westrop, and J. W. Almond. 1985. Principal and subsidiary antigenic sites of VP1 involved in the neutralization of poliovirus type 3. J. Gen. Virol. 66:1159-1165.
16. Minor, P. D., M. Ferguson, D. M. A. Evans, J. W. Almond, and J. P. Icenogle. 1986. Antigenic structure of poliovirus of serotypes 1, 2, and 3. J. Gen. Virol. 67:1283-1291.
17. Mulders, M. N., J. H. J. Reimerink, M. Stenvik, I. Alaeddinoglu, H. G. A. M. van der Avoort, T. Hovi, and M. P. G. Koopmans. 1999. A Sabin vaccine-derived field isolate of poliovirus type 1 displaying aberrant phenotypic and genetic features including a deletion in antigenic site 1. J. Gen. Virol. 80: 907-916.
18. Nibbeling, R., J. H. J. Reimerink, M. Agboatwala, T. Naquid, A. Ras, P. Poelstra, H. A. G. M. van der Avoort, and A. M. van Loon. 1994. A poliovirus type-specific IgM antibody-capture enzyme-linked immunosorbent assay for the rapid diagnosis of poliomyelitis. Clin. Diagn. Virol. 2:113-126.
19. Oostvogel, P. M., J. K. Wijngaarden, H. G. A. M. van der Avoort, M. N. Mulders, M. A. E. Conyn-van Spaendonck, H. C. Rumke, G. van Steenis, and A. M. van Loon. 1994. Poliomyelitis outbreak in an unvaccinated community in The Netherlands 1992-93. Lancet 344:665-670.
20. Osterhaus, A. D. M. E., A. L. van Wezel, T. G. Hazendonk, F. G. C. M. Uytdehaag, J. A. A. M. van Asten, and B. van Steenis. 1983. Monoclonal antibodies to polioviruses: comparison of intratypic strain differentiation of poliovirus type 1 using monoclonals versus cross-absorbed antisera. Intervirology 20:129-136.
21. Page, G. S., A. G. Mosser, J. M. Hogle, D. J. Filman, R. R. Rueckert, and M. Chow. 1988. Three-dimensional structure of poliovirus serotype 1 neutralizing determinants. J. Virol. 62:1781-1794.
22. Patel, V., M. Ferguson, and P. D. Minor. 1993. Antigenic sites on type 2 poliovirus. Virology 192:361-364.
23. Piirainen, L., M. Roivainen, L. Litmanen, J. Eskola, C. Beuvery, and T. Hovi. 1997. Immunogenicity of a pilot inactivated poliovirus vaccine with trypsintreated type 3-component. Vaccine 15:237-243.
24. Puig, M., J. Jofre, F. Lucena, A. Allard, G. Wadell, and R. Girones. 1994. Detection of adenoviruses and enteroviruses in polluted waters by nested PCR amplification. Appl. Environ. Microbiol. 60:2963-2970.
25. Roivainen, M., and T. Hovi. 1987. Intestinal trypsin can significantly modify antigenic properties of polioviruses: implications for the use of inactivated poliovirus vaccine. J. Virol. 61:3749-3753.
26. Simons, J. U., M. Kutubuddin, and M. Chow. 1993. Characterization of poliovirus-specific T lymphocytes in the peripheral blood of Sabin-vaccinated humans. J. Virol. 67:1262-1268.
27. Van der Avoort, H. G. A. M., J. H. J. Reimerink, A. Ras, M. N. Mulders, A. M. van Loon. 1995. Isolation of epidemic poliovirus from sewage during the 1992-93 type 3 outbreak in The Netherlands. Epidemiol. Infect. 114:481-491.
28. Van der Marel, P., T. G. Hazendonk, M. A. Henneke, and A. L. van Wezel. 1983. Induction of neutralizing antibodies by poliovirus capsid polypeptides VP1, VP2, and VP3. Vaccine 1:17-22.